| Merck Wins Panel Backing for Vytorin in Some Kidney Patients - BusinessWeek |
|
|
BusinessWeek The panel voted 16-0 during a meeting today in Silver Spring, Maryland, that the Food and Drug Administration should approve Vytorin to treat patients with kidney disease who aren't on dialysis. The advisers also decided 10-6 that the drug shouldn't be ... US advisers back Vytorin in some kidney patients Reuters FDA advisory panel recommends Vytorin for CVD prevention in predialysis CKD |